(Q37443855)

20 August 2017

1 reference

title

Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact? (English)

1 reference

20 August 2017

author

Valentín Fuster Carulla

series ordinal

3

1 reference

20 August 2017

Diana A Gorog

1

1 reference

20 August 2017

Joseph M Sweeny

series ordinal

2

1 reference

20 August 2017

language of work or name

English

0 references

publication date

14 April 2009

1 reference

Nature Reviews Cardiology

20 August 2017

published in

1 reference

20 August 2017

volume

6

1 reference

20 August 2017

issue

5

1 reference

20 August 2017

page(s)

365-373

1 reference

Human blood platelet behaviour after inhibition of thromboxane synthetase

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

High-dose aspirin inhibits shear-induced platelet reaction involving thrombin generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Response to aspirin and clopidogrel monitored with different platelet function methods

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Resistance to clopidogrel: a review of the evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Drug insight: Clopidogrel nonresponsiveness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Aspirin and clopidogrel resistance: consideration and management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Dual antiplatelet agent failure: a new syndrome or clinical nonentity?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Major clinical vascular events and aspirin-resistance status as determined by the PFA-100 method among patients with stable coronary artery disease: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Antiplatelet drug 'resistance'. Part 1: mechanisms and clinical measurements

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Ionized calcium in normal serum, ultrafiltrates, and whole blood determined by ion-exchange electrodes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Development of eptifibatide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Critical Importance of Citrate–Blood Ratio in Platelet Aggregation Studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Aspirin and clopidogrel resistance in patients with diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Platelet aggregation, sensitivity to prostaglandin E1 and thromboxane A2 release in recombinant hirudin- and heparin-anticoagulated blood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Citrate anticoagulation and the dynamics of thrombin generation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

The release of nucleotides, 5-hydroxytryptamine and enzymes from human blood platelets during aggregation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Reproducibility of platelet function testing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

ADP-induced platelet aggregation in young female survivors of acute myocardial infarction and their female controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Alterations of adenine nucleotide metabolism and function of blood platelets in patients with diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Factors responsible for ADP-induced release reaction of human platelets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Adenosine diphosphate(ADP) does not induce thromboxane A2 generation in human platelets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Human neutrophil cathepsin G is a potent platelet activator

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Plasma leukocyte elastase concentration in angiographically diagnosed coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Concentration of leukocyte elastase in plasma and polymorphonuclear neutrophil extracts in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Changes in the polymorphonuclear leukocyte function of blood samples induced by storage time, temperature and agitation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Citrate storage affects Thrombelastograph analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Inhibition of thromboxane synthetase does not necessarily prevent platelet aggregation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Dose- and time-dependent antiplatelet effects of aspirin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

No case of COX-1-related aspirin resistance found in 289 patients with symptoms of stable CHD remitted for coronary angiography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Variability in platelet responses to collagen--comparison between whole blood perfusions, traditional platelet function tests and PFA-100.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Effect on human platelets of catecholamines at levels achieved in the circulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Whole blood platelet aggregation in humans and animals: a comparative study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Evaluation of platelet function in aspirin treated patients with CAD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Prevalence of impaired responsiveness to epinephrine in platelets among Japanese

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Depressed responsiveness to adrenaline in platelets from apparently normal human donors: a familial trait

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Quantifying the effect of antiplatelet therapy: a comparison of the platelet function analyzer (PFA-100) and modified thromboelastography (mTEG) with light transmission platelet aggregometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

The platelet inhibiting effect of a clopidogrel bolus dose in patients on long-term acetylsalicylic acid treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Monitoring of clopidogrel action: comparison of methods

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Clopidogrel-induced platelet inhibition cannot be detected by the platelet function analyzer-100 system in stroke patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Variable responses to inhibition of fibrinogen binding induced by tirofiban and eptifibatide in blood from healthy subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Individual variations of platelet inhibition after loading doses of clopidogrel

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Impact of adenosine diphosphate and calcium chelation on platelet aggregation testing in patients receiving clopidogrel therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Calcium threshold in human plasma clotting kinetics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Human platelets synthesize and express functional tissue factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Platelet ADP receptors contribute to the initiation of intravascular coagulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Influence of low- and high-dose aspirin treatment on thrombin generation in whole blood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Role of protease-activated and ADP receptor subtypes in thrombin generation on human platelets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Clinical implications of aspirin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Cytochrome p-450 polymorphisms and response to clopidogrel

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Genetic determinants of response to clopidogrel and cardiovascular events

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.13

Neutrophil activation detected by increased neutrophil elastase activity in type 1 (insulin-dependent) diabetes mellitus

31 March 2020

1 reference

12 December 2020

Evidence for a role in thrombus stabilization for thromboxane A2 in human platelet deposition on collagen

1 reference

12 December 2020

Nonreversible loss of platelet aggregability induced by calcium deprivation

1 reference

12 December 2020

Clopidogrel--a platelet inhibitor which inhibits thrombogenesis in non-anticoagulated human blood independently of the blood flow conditions

1 reference

12 December 2020

Effect of aspirin and dipyridamole on the interaction of human platelets with sub-endothelium: studies using citrated and native blood

1 reference

12 December 2020

Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation

1 reference

12 December 2020

Aspirin resistance in diabetic patients: laboratory entity or clinical reality?

1 reference

12 December 2020

Collagen-induced platelet aggregation: the role of adenine nucleotides and the release reaction

1 reference

12 December 2020

A time-dependent increase in the responsiveness of platelet-rich plasma to epinephrine

1 reference

12 December 2020

Conditions affecting the responses of human platelets to epinephrine

1 reference

12 December 2020

Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty

1 reference

12 December 2020

Role of cytoplasmic and releasable ADP in platelet aggregation induced by laminar shear stress

1 reference

12 December 2020

Role of collagen-adherent platelets in mediating fibrin formation in flowing whole blood

1 reference

12 December 2020

Lowered serum ionized calcium in insulin treated diabetic subjects

1 reference

12 December 2020

The interaction of extracellular calcium with the platelet membrane glycoprotein IIb-IIIa complex

1 reference

12 December 2020

Epinephrine potentiates human platelet activation but is not an aggregating agent

1 reference

12 December 2020

ADP-induced platelet aggregation as a function of age in healthy humans

1 reference

12 December 2020

Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition

1 reference

12 December 2020

Neutrophil elastase potentiates cathepsin G-induced platelet activation

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRCARDIO.2009.13

1 reference

20 August 2017

1 reference